相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Natural killer cells and anti-tumor immunity
Sandra E. Nicholson et al.
MOLECULAR IMMUNOLOGY (2019)
Docetaxel promotes the generation of anti-tumorigenic human macrophages
Camilla Rydberg Millrud et al.
EXPERIMENTAL CELL RESEARCH (2018)
NKp46 Receptor-Mediated Interferon-γ Production by Natural Killer Cells Increases Fibronectin 1 to Alter Tumor Architecture and Control Metastasis (vol 48, pg 107, 2018)
Ariella Glasner et al.
IMMUNITY (2018)
Immune Checkpoint Inhibitor Toxicity in 2018
Douglas B. Johnson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Combining DNA damaging therapeutics with immunotherapy: more haste, less speed
Jessica S. Brown et al.
BRITISH JOURNAL OF CANCER (2018)
DRUG PAIRING Combinations on trial
Charles Schmidt
NATURE (2017)
Natural Killer Cell Response to Chemotherapy-Stressed Cancer Cells: Role in Tumor Immunosurveillance
Alessandra Zingoni et al.
FRONTIERS IN IMMUNOLOGY (2017)
The immune system in cancer metastasis: friend or foe?
Louise M. E. Janssen et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2017)
Tubb3 regulation by the Erk and Akt signaling pathways: a mechanism involved in the effect of arginine ADP-ribosyltransferase 1 (Art1) on apoptosis of colon carcinoma CT26 cells
Ming Xiao et al.
TUMOR BIOLOGY (2016)
Taxanes enhance trastuzumab-mediated ADCC on tumor cells through NKG2D-mediated NK cell recognition
Martina Di Modica et al.
ONCOTARGET (2016)
Pro-Inflammatory Effects of Colchicine on Macrophages Stimulated with Atherogenic Stimuli in Vitro
N. Schwarz et al.
Heart Lung and Circulation (2016)
Innate immune mediators in cancer: between defense and resistance
Pedro Berraondo et al.
IMMUNOLOGICAL REVIEWS (2016)
Phase I Study of Nivolumab plus Nab-Paclitaxel in Solid Tumors: Preliminary Analysis of the Non-Small Cell Lung Cancer Cohort
Ben George et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
Progress in adjuvant chemotherapy for breast cancer: an overview
Jesus Anampa et al.
BMC MEDICINE (2015)
Colchicine Significantly Reduces Incident Cancer in Gout Male Patients A 12-Year Cohort Study
Ming-Chun Kuo et al.
MEDICINE (2015)
Colchicine-Update on mechanisms of action and therapeutic uses
Ying Ying Leung et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2015)
Cracking the (tubulin) code of mitosis
Marin Barisic et al.
ONCOTARGET (2015)
How Taxol/paclitaxel kills cancer cells
Beth A. Weaver
MOLECULAR BIOLOGY OF THE CELL (2014)
Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL): a multicentre, double-blind, randomised phase 3 trial
Edward B. Garon et al.
LANCET (2014)
Selective Depletion of Regulatory T Cell Subsets by Docetaxel Treatment in Patients with Nonsmall Cell Lung Cancer
Jie-Yao Li et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2014)
Microtubules and their role in cellular stress in cancer
Amelia L. Parker et al.
FRONTIERS IN ONCOLOGY (2014)
T cell responses: naive to memory and everything in between
Nathan D. Pennock et al.
ADVANCES IN PHYSIOLOGY EDUCATION (2013)
Monocytes in Coronary Artery Disease and Atherosclerosis Where Are We Now?
Angie Ghattas et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Anti-cancer mechanisms of clinically acceptable colchicine concentrations on hepatocellular carcinoma
Zu-Yau Lin et al.
LIFE SCIENCES (2013)
Monocytes and Macrophages in Cancer: Development and Functions
David M. Richards et al.
CANCER MICROENVIRONMENT (2013)
M1 and M2 Macrophages: Oracles of Health and Disease
Charles D. Mills
CRITICAL REVIEWS IN IMMUNOLOGY (2012)
Taxanes for the Treatment of Metastatic Breast Cancer
W. J. Gradishar
BREAST CANCER-BASIC AND CLINICAL RESEARCH (2012)
Cancer immunotherapy comes of age
Ira Mellman et al.
NATURE (2011)
Specific microtubule-depolymerizing agents augment efficacy of dendritic cell-based cancer vaccines
Chih-Chun Wen et al.
JOURNAL OF BIOMEDICAL SCIENCE (2011)
Nomenclature of monocytes and dendritic cells in blood
Loems Ziegler-Heitbrock et al.
BLOOD (2010)
Differential effects of Paclitaxel on dendritic cell function
Justin John et al.
BMC IMMUNOLOGY (2010)
Development of Monocytes, Macrophages, and Dendritic Cells
Frederic Geissmann et al.
SCIENCE (2010)
Paclitaxel reduces regulatory T cell numbers and inhibitory function and enhances the anti-tumor effects of the TLR9 agonist PF-3512676 in the mouse
Alain P. Vicari et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Classification of Chemotherapeutic Agents Based on Their Differential In vitro Effects on Dendritic Cells
Hiroaki Tanaka et al.
CANCER RESEARCH (2009)
Dual Therapeutic Efficacy of Vinblastine as a Unique Chemotherapeutic Agent Capable of Inducing Dendritic Cell Maturation
Hiroaki Tanaka et al.
CANCER RESEARCH (2009)
Colchicine promotes antigen cross-presentation by murine dendritic cells
Norikatsu Mizumoto et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2007)
Breast cancer instructs dendritic cells to prime interleukin 13-secreting CD4+ T cells that facilitate tumor development
Caroline Aspord et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Effect of frequently used chemotherapeutic drugs on the cytotoxic activity of human natural killer cells
Laszlo Markasz et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Increased surveillance of cells in mitosis by human NK cells suggests a novel strategy for limiting tumor growth and viral replication
Esther N. M. Nolte-'t Hoen et al.
BLOOD (2007)
Potential for improvement of docetaxel-based chemotherapy: a pharmacological review
FK Engels et al.
BRITISH JOURNAL OF CANCER (2005)
Structural basis for the regulation of tubulin by vinblastine
B Gigant et al.
NATURE (2005)
Paclitaxel probably enhances cytotoxicity of natural killer cells against breast carcinoma cells by increasing perforin production
M Kubo et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2005)
Concomitant tumor immunity to a poorly immunogenic melanoma is prevented by regulatory T cells
MJ Turk et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
The mature activating natural killer cell immunologic synapse is formed in distinct stages
JS Orange et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Mode of action of docetaxel - a basis for combination with novel anticancer agents
RS Herbst et al.
CANCER TREATMENT REVIEWS (2003)
Coexpression of CD58 or CD48 with intercellular adhesion molecule 1 on target cells enhances adhesion of resting NK cells
DF Barber et al.
JOURNAL OF IMMUNOLOGY (2003)
Immune changes in patients with advanced breast cancer undergoing chemotherapy with taxanes
N Tsavaris et al.
BRITISH JOURNAL OF CANCER (2002)
CD11b/CD18 acts in concert with CD14 and Toll-like receptor (TLR) 4 to elicit full lipopolysaccharide and taxol-inducible gene expression
PY Perera et al.
JOURNAL OF IMMUNOLOGY (2001)
分享论文
